Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens

Completed · Phase 4

Conditions studied: Rosacea

In brief

To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%

Key facts

Study ID

NCT00495313

Run by

CollaGenex Pharmaceuticals

People needed

91

Starts

2007-03-01

Expected to finish

2007-12-01

Last updated by the study team

2008-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 8-40 total lesions
• erythema
• telangiectasia

You may not qualify if…

• non-pregnant, non-lactating
• achlorhydric
• gastric by-pass surgery
• allergy to study medications
• drug/alcohol abuse
• use of proton pump inhibitors

Where it is running

• Joel Schlessinger — Omaha, Nebraska, United States
• James Del Rosso — Las Vegas, Nevada, United States
• Angela Moore — Arlington, Texas, United States
• William Abramovits — Dallas, Texas, United States
• Douglas Forsha — West Jordan, Utah, United States
• Bernard Goffe — Seattle, Washington, United States
• William Werschler — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.